| References |
Top |
| REF 1 |
Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells. J Biol Chem. 2006 Jul 28;281(30):20817-24.
|
| REF 2 |
MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem. 2002 Aug 23;277(34):30838-43.
|
| REF 3 |
PCAF is a coactivator for p73-mediated transactivation. Oncogene. 2003 Nov 13;22(51):8316-29.
|
| REF 4 |
A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol. 1998 Sep;18(9):5355-63.
|
| REF 5 |
Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010 Jun 25;38(6):864-78.
|
| REF 6 |
Dimeric structure of p300/CBP associated factor. BMC Struct Biol. 2014 Jan 14;14:2.
|
| REF 7 |
Parathyroid hormone activation of matrix metalloproteinase-13 transcription requires the histone acetyltransferase activity of p300 and PCAF and p300-dependent acetylation of PCAF. J Biol Chem. 2010 Dec 3;285(49):38014-22.
|
| REF 8 |
BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene. 1998 Nov 12;17(19):2531-4.
|
| REF 9 |
Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell. 2006 Apr 21;22(2):231-43.
|
| REF 10 |
Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509.
|
| REF 11 |
p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity. Eur J Immunol. 2013 Aug;43(8):2174-84.
|
| REF 12 |
Characterization of a novel transcriptionally active domain in the transforming growth factor beta-regulated Smad3 protein. Nucleic Acids Res. 2005 Jul 1;33(12):3708-21.
|
